Abstract

Mitochondria have been identified to be involved in oxidative phosphorylation, lipid metabolism, cell death, and cell proliferation. Previous studies have demonstrated that mitoguardin (Miga), a mitochondrial protein that governs mitochondrial fusion, mitochondria-endoplasmic reticulum (ER) contacts, lipid formation, and autophagy, is crucial for ovarian endocrine and follicular development. Nevertheless, whether mammalian MIGA1 or MIGA2 (MIGA1,-2) regulates ovarian granulosa cell proliferation remains unclear. This study revealed that mammalian MIGA1,-2 promotes cell proliferation and regulates the phosphorylation and localization of Yes-associated protein 1 (YAP1) in ovarian granulosa cells. MIGA2 upregulation resulted in reduced YAP1 activity, while MIGA2 removal led to increased YAP1 activity. Further analysis indicated that MIGA1,-2 regulated YAP1 via the Hippo signaling pathway and regulated protein kinase B (AKT) activity in collaboration with YAP1. In addition, lysophosphatidic acid (LPA) regulated MIGA2 expression and AKT activity by activating YAP1. Briefly, we demonstrated that the mitochondrial MIGA1 and MIGA2, especially MIGA2, promoted cellular proliferation by activating AKT and regulating the Hippo/YAP1 signaling pathway in ovarian granulosa cells, which may contribute to the molecular pathogenesis of reproductive endocrine diseases, such as polycystic ovary syndrome (PCOS).

Details

Title
Mitoguardin 1 and 2 promote granulosa cell proliferation by activating AKT and regulating the Hippo-YAP1 signaling pathway
Author
Yan, Ming-Qi 1 ; Zhu, Bing-Hong 2 ; Liu, Xiao-Hong 3 ; Yang, Yu-Meng 1 ; Duan, Xiu-Yun 1 ; Wang, Yong 4 ; Sun, Hui 4 ; Feng, Mei 5 ; Li, Tao 6 ; Liu, Xiao-Man 7   VIAFID ORCID Logo 

 Shandong University, Department of Central Laboratory, Shandong Provincial Hospital, Jinan, China (GRID:grid.27255.37) (ISNI:0000 0004 1761 1174) 
 The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Department of Obstetrics and Gynecology, Jinan, China (GRID:grid.452422.7) (ISNI:0000 0004 0604 7301) 
 Jen Ching Memorial Hospital, Department of Infection Control, Kunshan, China (GRID:grid.452422.7) 
 Shandong Provincial Hospital Affiliated to Shandong First Medical University; Institute of Clinical Microbiology, Shandong Academy of Clinical Medicine, Department of Clinical Laboratory Medicine, Jinan, China (GRID:grid.460018.b) (ISNI:0000 0004 1769 9639) 
 Shandong University, Department of Central Laboratory, Shandong Provincial Hospital, Jinan, China (GRID:grid.27255.37) (ISNI:0000 0004 1761 1174); Shandong Provincial Hospital Affiliated to Shandong First Medical University, Department of Central Laboratory, Jinan, China (GRID:grid.410587.f) 
 Shandong Provincial Hospital Affiliated to Shandong First Medical University, Department of Obstetrics and Gynecology, Jinan, China (GRID:grid.410587.f) 
 Shandong University, Department of Central Laboratory, Shandong Provincial Hospital, Jinan, China (GRID:grid.27255.37) (ISNI:0000 0004 1761 1174); Shandong Provincial Hospital Affiliated to Shandong First Medical University; Institute of Clinical Microbiology, Shandong Academy of Clinical Medicine, Department of Clinical Laboratory Medicine, Jinan, China (GRID:grid.460018.b) (ISNI:0000 0004 1769 9639); Shandong Provincial Hospital Affiliated to Shandong First Medical University, Department of Central Laboratory, Jinan, China (GRID:grid.410587.f) 
Pages
779
Publication year
2023
Publication date
Nov 2023
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2894164138
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.